Close Cookie Popup
Cookie Preferences
By clicking “Accept All”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts as outlined in our cookie policy.
Strictly Necessary (Always Active)
Cookies required to enable basic website functionality.
Cookies helping us understand how this website performs, how visitors interact with the site, and whether there may be technical issues.
Cookies used to deliver advertising that is more relevant to you and your interests.
Cookies allowing the website to remember choices you make (such as your user name, language, or the region you are in).
Customize
Save
Decline All
Accept All

Insights

Welcome to NLC Insights, your gateway to the latest developments, innovations, and news about our healthcare innovations.

News
Venture launches
Insights
Type
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Jul 2024
Nina Rijnders: Impact investing for philanthropic fund (In Dutch)
Insights

Nina Rijnders: Impact investing for philanthropic fund (In Dutch)

Insights

Nina Rijnders: Impact investing for philanthropic fund (In Dutch)

Jul 2024
SERDA Therapeutics Announces Completion of First Phase 1 Clinical Study of SN514
News

SERDA Therapeutics Announces Completion of First Phase 1 Clinical Study of SN514

News

SERDA Therapeutics Announces Completion of First Phase 1 Clinical Study of SN514

Jun 2024
Introducing Exolvo: NLC Health Ventures launches new early-stage drug delivery company
Venture launches

Introducing Exolvo: NLC Health Ventures launches new early-stage drug delivery company

Venture launches

Introducing Exolvo: NLC Health Ventures launches new early-stage drug delivery company

Jun 2024
Dutch health insurer VGZ invests €6 million in NLC Health Ventures
News

Dutch health insurer VGZ invests €6 million in NLC Health Ventures

News

Dutch health insurer VGZ invests €6 million in NLC Health Ventures

May 2024
NLC was named the Number 1 Most Active Early Stage Investor in Healthcare in Europe by Financial Times’ Sifted
News

NLC was named the Number 1 Most Active Early Stage Investor in Healthcare in Europe by Financial Times’ Sifted

News

NLC was named the Number 1 Most Active Early Stage Investor in Healthcare in Europe by Financial Times’ Sifted

May 2024
NLC venture Altach secures €1.2 million investment to transform treatments for cartilage injuries
News

NLC venture Altach secures €1.2 million investment to transform treatments for cartilage injuries

News

NLC venture Altach secures €1.2 million investment to transform treatments for cartilage injuries

May 2024
NLC completes first close of €100 million health impact fund
News

NLC completes first close of €100 million health impact fund

News

NLC completes first close of €100 million health impact fund

Apr 2024
AI Healthtech start-up MindAffect raises €1.1 million to transform hearing diagnostics
News

AI Healthtech start-up MindAffect raises €1.1 million to transform hearing diagnostics

News

AI Healthtech start-up MindAffect raises €1.1 million to transform hearing diagnostics

Apr 2024
IPD secures funding of €2.1 million to initiate its first-in-human trials for prosthetic joint infections
News

IPD secures funding of €2.1 million to initiate its first-in-human trials for prosthetic joint infections

News

IPD secures funding of €2.1 million to initiate its first-in-human trials for prosthetic joint infections

Feb 2024
Introducing Aerion Bioscience: A new era of cancer screening
Venture launches

Introducing Aerion Bioscience: A new era of cancer screening

Venture launches

Introducing Aerion Bioscience: A new era of cancer screening

Jan 2024
CUIP and NLC Health Ventures signed a MoU to bring cutting-edge innovations to life
News

CUIP and NLC Health Ventures signed a MoU to bring cutting-edge innovations to life

News

CUIP and NLC Health Ventures signed a MoU to bring cutting-edge innovations to life

Dec 2023
POROUS wins innovation award
News

POROUS wins innovation award

News

POROUS wins innovation award

Dec 2023
Ansana secures a €850,000 investment
News

Ansana secures a €850,000 investment

News

Ansana secures a €850,000 investment

Dec 2023
Introducing LiftYa: Stability with motion
Venture launches

Introducing LiftYa: Stability with motion

Venture launches

Introducing LiftYa: Stability with motion

Nov 2023
Introducing StarTric: Transcatheter tricuspid heart valve repair
Venture launches

Introducing StarTric: Transcatheter tricuspid heart valve repair

Venture launches

Introducing StarTric: Transcatheter tricuspid heart valve repair

Nov 2023
Introducing Amotio: Revolutionising orthopaedic revision surgery: An innovative approach to major joint implant revisions
Venture launches

Introducing Amotio: Revolutionising orthopaedic revision surgery: An innovative approach to major joint implant revisions

Venture launches

Introducing Amotio: Revolutionising orthopaedic revision surgery: An innovative approach to major joint implant revisions

No journals are available with your current selection of filters. Please adjust your search criteria and try again.